Pharvaris N.V.
PHVS
$23.65
$0.532.29%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 0.33% | 11.51% | 60.54% | 59.70% | 43.92% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 23.82% | 44.44% | 64.26% | 46.11% | 51.40% |
| Operating Income | -23.82% | -44.44% | -64.26% | -46.11% | -51.40% |
| Income Before Tax | -60.96% | -60.92% | -3.72% | -78.65% | -34.51% |
| Income Tax Expenses | 202.76% | 2.91% | 64.09% | 58.92% | -25.85% |
| Earnings from Continuing Operations | -61.30% | -60.33% | -5.10% | -78.53% | -34.25% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -61.30% | -60.33% | -5.10% | -78.53% | -34.25% |
| EBIT | -23.82% | -44.44% | -64.26% | -46.11% | -51.40% |
| EBITDA | -23.92% | -44.63% | -64.23% | -46.41% | -51.52% |
| EPS Basic | -59.08% | -58.16% | 14.49% | -35.09% | 13.99% |
| Normalized Basic EPS | -58.77% | -58.73% | 15.62% | -35.15% | 13.84% |
| EPS Diluted | -59.08% | -58.16% | 14.49% | -35.09% | 13.99% |
| Normalized Diluted EPS | -58.77% | -58.73% | 15.62% | -35.15% | 13.84% |
| Average Basic Shares Outstanding | 1.39% | 1.38% | 22.91% | 32.17% | 56.09% |
| Average Diluted Shares Outstanding | 1.39% | 1.38% | 22.91% | 32.17% | 56.09% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |